Association of glycoprotein gp130 with hereditary catalepsy in mice

Genes, Brain and Behavior

Volumn 9, Issue 8, 2010, Pages 997-1003

  Kulikov, A V ^a   Sinyakova, N A ^a   Naumenko, V S ^a   Bazovkina, D V ^a   Popova, N K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Aggression; Brain; Catalepsy; Congenic mice; GFAP; Gp130; Lipopolysaccharide; Open field test; Social investigation test

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MESSENGER RNA;

AKR MOUSE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CATALEPSY; CONGENIC RESISTANT STRAIN; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; LOCOMOTION; MALE; MESENCEPHALON; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BRAIN; CATALEPSY; CYTOKINE RECEPTOR GP130; EXPLORATORY BEHAVIOR; FRONTAL LOBE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; ILLNESS BEHAVIOR; LIPOPOLYSACCHARIDES; MALE; MESENCEPHALON; MICE; MICE, INBRED AKR; MICE, TRANSGENIC; SOCIAL BEHAVIOR;

BACTERIA (MICROORGANISMS); MUS;

EID: 78349243241     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2010.00639.x     Document Type: Article

References (46)

1. Anisman, H., Hayley, S., Turrin, N. & Merali, Z. (2002) Cytokines as a stressor: implications for depressive illness. Int J Neuropsychopharmacol 5, 357-373.
2. Bazovkina, D.V. & Kulikov, A.V. (2009) Cataleptogenic effect of bacterial lipopolysaccharide in mice. Dokl Biol Sci 428, 410-411.
3. Bluthe, R.-M., Michaud, B., Poli, V. & Dantzer, R. (2000) Role of IL-6 in cytokine induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav 70, 367-373.
4. Butterweck, V., Prinz, S. & Schwaninger, M. (2003) The role of interleukin-6 in stress-induced hyperthermia and emotional behavior in mice. Behav Brain Res 144, 49-56.
5. Chesnokova, V. & Melmed, S. (2002) Minireview: neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinol 143, 1571-1574.
6. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by guanidinium thiocyanate - phenol - chloroform extraction. Anal Biochem 162, 156-159.
7. Connor, T.J., Song, C., Leonard, B.E., Merali, Z. & Aniaman, H. (1998) An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioral, neurochemical, endocrine and immune parameters in the rat. Neurosci 84, 923-933.
8. Conroy, S.M., Nguyen, V., Quina, L.A., Blakely-Gonzales, P., Ur, C., Netzeband, J.G., Prieto, A.L. & Gruol, D.L. (2004) Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J Neuroimmunol 155, 43-54.
9. Dahlstrom, A. & Fuxe, K. (1964) Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62 (Suppl. 232), 1-80.
10. Dantzer, R. (2001) Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 933, 222-234.
11. Dixon, A.K. (1998) Ethological strategies for defense in animals and humans: their role in some psychiatric disorders. Br J Med Psychol 71, 417-445.
12. Dunn, A.J. (2006) Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 6, 52-68.
13. Dunn, A.J., Wang, J. & Ando, T. (1999) Effects of cytokines on central neurotransmission: comparison with the effects of stress. Adv Exp Med Biol 461, 117-127.
14. Fasnacht, N. & Muller, W. (2008) Conditional gp130 different mouse mutants. Semin Cell Dev Biol 19, 379-384.
15. Frenois, F., Moreau, M., O'Connor, J., Lawson, M., Micon, C., Lestage, J., Kelley, K.W., Dantzer, R. & Castanon, N. (2007) Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinol 32, 516-531.
16. Gasparotto, O.C., Carobrez, S.G. & Bohus, B.G. (2007) Effects of LPS on the behavioural stress response of genetically selected aggressive and nonaggressive wild house mice. Behav Brain Res 183, 52-59.
17. Hayley, S., Poulter, M.O., Merali, Z. & Anisman, H. (2005) The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neurosci 135, 659-678.
18. Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Muller-Newen, G. & Schaper, F. (2003) Principles of interleukin (IL)-6-type cytokine signaling and regulation. Biochem J 374, 1-20.
19. Islam, O., Gong, X., Rose-John, S. & Heese, K. (2009) Interleukin-6 and neural stem cells: more than gliogenesis. Mol Biol Cell 20, 188-199.
20. Jacobs, B.L. & Azmitia, E.C. (1992) Structure and function of the brain serotonin system. Physiol Rev 72, 165-229.
21. Klemm, W.R. (1989) Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog Neurobiol 32, 403-422.
22. 1A serotonin receptor gene in mice. Genes Brain Behav 5, 596-601.
23. Kondaurova, E.M., Bazovkina, D.V. & Kulikov, A.V. (2010) Study of the association between catalepsy, anxiety, aggression and depressive-like behavior in congenic mice. Russ Physiol J 96, 464-471.
24. Kulikov, A., Kozlachkova, E., Maslova, G. & Popova, N. (1993) Inheritance of predisposition to catalepsy in mice. Behav Genet 23, 379-384.
25. Kulikov, A.V. & Naumenko, V.S. (2007) Problems of mRNA quantification in the brain using RT-PCR. In Kwang, L.B. (ed), New Messenger RNA Research Communications. Nova Science Publishers, New York, pp. 53-68.
26. Kulikov, A.V., Bazovkina, D.V., Moisan, M.-P. & Mormede, P. (2003) The mapping of the gene of susceptibility to catalepsy in mice using polymorphic microsatellite markers. Dokl Biol Sci 393, 531-534.
27. 2A serotonin receptor mRNAs using genomic DNA as an standard. J Neurosci Meth 141, 97-101.
28. Kulikov, A.V., Bazovkina, D.V., Kondaurova, E.M. & Popova, N.K. (2008a) Genetic structure of hereditary catalepsy in mice. Genes Brain Behav 7, 506-512.
29. Kulikov, A.V., Tikhonova, M.A. & Kulikov, V.A. (2008b) Automated measurement of special preference in the open field test with transmitted lighting. J Neurosci Meth 170, 345-351.
30. Lee, H.K., Seo, I.A., Suh, D.J., Hong, J.-I., Yoo, Y.H. & Park, H.T. (2009) Interleukin-6 is required for the early induction of glial fibrillary acidic protein in Schwann cells during Wallerian degeneration. J Neurochem 108, 776-786.
31. Lesch, K.P. 2004. Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci 29, 174-184.
32. Lucki, I. (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiat 44, 151-162.
33. Naka, T., Nishimoto, N. & Kishimoto, T. (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4, S233-S242.
34. Naumenko, V.S. & Kulikov, A.V. (2006) Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol Biol 40, 37-44.
35. Naumenko, V.S., Osipova, D.V., Kostina, E.V. & Kulikov, A.V. (2008) Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J Neurosci Meth 170, 197-203.
36. Popova, N.K. (2006) From genes to aggressive behavior: the role of serotonergic system. Bioessays 28, 495-503.
37. Popova, N. & Kulikov A. (1995) On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models. Am J Med Genet (Neuropsychiatric Genet) 60, 214-220.
38. Singerman, B. & Raheja, R. (1994) Malignant catatonia - a continuing reality. Ann Clin Psychiatry 6, 259-266.
39. Sriram, K., Benkovic, S.A., Hebert, M.A., Miller, D.B. & O'Callaghan, J.P. (2004) Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes proceeds up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J Biol Chem 279, 19936-19947.
40. Swiergiel, A.H. & Dunn, A.J. (2006) Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171, 94-108.
41. Swiergiel, A.H. & Dunn, A.J. (2007) Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol Biochem Behav 86, 651-659.
42. Takanaga, H., Yoshitake, T., Hara, S., Yamasaki, C. & Kunimoto, M. (2004) cAMP-induced astrocytic differentiation of C6 glioma cells is mediated by autocrine interleukin-6. J Biol Chem 279, 15441-15447.
43. Taylor, M.A. & Fink, M. (2003) Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160, 1233-1241.
44. Wang, J.P. & Dunn, A.J. (1998) Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem Int 33, 143-154.
45. Zalcman, S., Green-Johnson, J.M., Murray, L., Nance, D.M., Dyck, D., Anisman, H. & Greenberg, A.H. (1994) Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643, 40-49.
46. Zhang, J.-J., Terreni, L., De Simoni, M.-G. & Dunn, A.J. (2001) Peripheral interleukin-6 administration increases extracellular concentration of serotonin and the evoked release of serotonin in the rat striatum. Neurochem Int 38, 303-308.